4//SEC Filing
Schneiderman Daniel H 4
Accession 0001213900-22-063616
CIK 0001841330other
Filed
Oct 11, 8:00 PM ET
Accepted
Oct 12, 8:15 PM ET
Size
5.5 KB
Accession
0001213900-22-063616
Insider Transaction Report
Form 4
Schneiderman Daniel H
Chief Financial Officer
Transactions
- Award
Stock Option (to acquire Common Stock)
2022-10-11+300,000→ 300,000 totalExercise: $1.26From: 2023-10-11Exp: 2032-10-11→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]The Reporting Person was granted 300,000 stock options. The stock options have a ten-year term and vest over three years, subject to Mr. Schneiderman remaining employed and in good standing, one-third vesting 12 months after the grant date, and the remainder vesting in equal tranches monthly for two years thereinafter.
Documents
Issuer
Pasithea Therapeutics Corp.
CIK 0001841330
Entity typeother
Related Parties
1- filerCIK 0001565536
Filing Metadata
- Form type
- 4
- Filed
- Oct 11, 8:00 PM ET
- Accepted
- Oct 12, 8:15 PM ET
- Size
- 5.5 KB